Abstracts tagged "Assessment"

Abstract Number: 1179 • ACR Convergence 2021
Determining Faculty vs. Fellow Preferences for ROSCE Milestone Assessments; Is It Time for a Change in Needs Assessment?
Sharon Banks¹, Seema Malkana² and Aruni Jayatilleke³, ¹Penn State Health, Hershey, PA, ²Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, ³Temple University, Philadelphia, PA
Background/Purpose: The Pennsylvania Rheumatology Objective Structured Clinical Examination (ROSCE) is an annual assessment of rheumatology fellows’ skills in different standardized patient (SP) encounters involving a…
Abstract Number: 176 • 2020 Pediatric Rheumatology Symposium
Implementation of an Abbreviated Neuropsychology Screening Protocol for Patients Diagnosed with Childhood-onset Systemic Lupus Erythematosus
Camille Wilson¹, Alana Leever ¹, Jennifer Cass ¹, Vidya Sivaraman ² and Stacy Ardoin ¹, ¹Nationwide Children's Hospital, Columbus, ²Division of Rheumatology, Nationwide Children's Hospital, Bexley
Background/Purpose: Research has established that a large percentage of individuals diagnosed with childhood-onset systemic lupus erythematosus (cSLE) report cognitive dysfunction. Disease factors that can impact…
Abstract Number: 425 • 2019 ACR/ARP Annual Meeting
Differences in Correlation Between Objective Disease Measurements and Patient’s/physician’s Global Assessment in the Large Non-interventional Study SUSTAIN
Jörg Wendler ¹, Peter Wagener ², Schwarze Ilka ³, Evgenia Movshovich⁴, Nils Damann ⁴ and Frank Behrens ⁵, ¹Rheumatologische Schwerpunktpraxis, Erlangen, Germany, ²Fachpraxis für Rheumatologie und Osteologie, Bruchhausen-Vilsen, Germany, ³Praxis für Innere Medizin und Rheumatologie, Leipzig, Germany, ⁴Janssen-Cilag, Neuss, Germany, ⁵Rheumatology Goethe-University Frankfurt & Fraunhofer IME-TMP, Frankfurt, Germany
Background/Purpose: The wish of a treating physician is to make sure, that the patient gets an effective and safe therapy and is satisfied with the…
Abstract Number: 1599 • 2019 ACR/ARP Annual Meeting
The Impact of Body Mass Index Variability in Systemic Lupus Erythematosus
Xuan Gao¹, Tejal Vashi ¹ and S Sam Lim ², ¹Emory University School of Medicine, Atlanta, GA, ²Emory University, Atlanta, GA
Background/Purpose: SLE is a chronic illness that carries both a physical and psychosocial burden, where the cumulative impact can lead to worse global outcomes. One…
Abstract Number: 393 • 2018 ACR/ARHP Annual Meeting
Physical Activity Monitoring Using Wrist-Worn Accelerometer in the Assessment and Follow-up of Patients with Myositis
Océane Landon-Cardinal¹, Damien Bachasson², Perrine Guillaume¹, Mathieu Vautier¹, Nicolas Champtiaux¹, Baptiste Hervier¹, Aude Rigolet¹, Olivier Benveniste¹, Jean-Yves Hogrel² and Yves Allenbach¹, ¹Department of Internal Medicine and Clinical Immunology and Inflammation-Immunopathology-Biotherapy Department (I2B), Pitié-Salpêtrière University Hospital, Assistance Publique-Hôpitaux de Paris, East Paris Neuromuscular Diseases Reference Center, Paris, France, ²Institute of Myology, Pitié-Salpêtrière University Hospital, Paris, France
Background/Purpose: Wrist-worn accelerometers allow the objective estimation of physical activity (PA) in daily life. Recently, the ENMC workshop on outcome measures in myositis suggested to…
Abstract Number: 644 • 2018 ACR/ARHP Annual Meeting
Influence of Inflammation and Structural Damage on Global Functioning in Patients with Axial Spondyloarthritis – Using the ASAS Health Index in Routine Care
Uta Kiltz¹, Thomas Wiatr², Xenofon Baraliakos¹, Kirill Fedorov² and Jürgen Braun³, ¹Rheumatology, Rheumazentrum Ruhrgebiet, Herne, and Ruhr University Bochum, Herne, Germany, ²Rheumazentrum Ruhrgebiet, Herne, Germany, ³Ruhr-University Bochum, Bochum, Germany
Background/Purpose: To investigate the relationship between spinal mobility and self-report global functioning as assessed by the ASAS Health Index (ASAS HI), and to study the…
Abstract Number: 1379 • 2018 ACR/ARHP Annual Meeting
Appraisal of the Educational Needs in Patients with Osteoarthritis Using the Educational Needs Assessment Tool Questionnaire
Adriana Garcia Coello¹, Oscar Rillo², Alejandro Brigante Jr.³, Maritza Quintero⁴, Yessica Ponce⁵, Rolando Espinoza⁶, Silvia Beatriz Papasidero⁷, Gonzalo Rodriguez⁸, Julia Sosa⁹, María Paula Kohan⁹, Dora Pereira¹⁰, Dafne Capelusnik¹¹, Lucy Heredia¹², Carlos Pineda¹³, Margarita González de Urizar¹⁴, Ana María Sapag Durán¹⁵, Cesar Rossi¹⁶, Pedro Santos-Moreno¹⁷, Vicente Juarez¹⁸, Jorge Esquivel-Valerio¹⁹, Vianna Khoury²⁰, Blanca Herrera Velasco²¹ and Renee Souto¹⁶, ¹Rheumatology Section, Hospital General de agudos Dr Ignacio Pirovano, Buenos Aires, Argentina, ²Hospital General de Agudos Dr Ignacio Pirovano, Argentina, Buenos Aires, Argentina, ³Sociedad Argentina de Reumatologia, Buenos Aires, Argentina, ⁴Rheumatology Section, Instituto Autónomo Hospital Universitario de Los Andes, Universidad de Los Andes, Venezuela, Mérida, Venezuela, ⁵Rheumatology Section, Hospital Genaral de agudos Dr Ignacio Pirovano, Argentina, Buenos Aires, Argentina, ⁶Rheumatology Section, Instituto Nacional de Rehabilitación, Luis Guillermo Ibarra Ibarra, Mexico, Mexico, Mexico, ⁷Rheumatology Section, Hospital General de Agudos Dr. Enrique Tornú, Argentina, Buenos Aires, Argentina, ⁸Hospital General de Agudos Dr Cosme Argerich, Argentina, Buenos Aires, Argentina, ⁹Rheumatology Section, Hospital General de Agudos Dr. Enrique Tornú, Argentina, CABA, Argentina, ¹⁰Rheumatology Section, Hospital Dr. Ricardo Gutiérrez, Argentina, Buenos Aires, Argentina, ¹¹Reumatology, Instituto de Rehabilitación Psicofísica, Argentina, CABA, Argentina, ¹²Hospital de Tercer Nivel Obrero Nº2 de la Caja Nacional de Salud, Bolivia, Cochabamba, Bolivia (Plurinational State of), ¹³Instituto Nacional de Rehabilitation, Mexico, Mexico, Mexico, ¹⁴Rheumatology, Hospital San Ramón, Paraguay, Ciudad del Este, Paraguay, ¹⁵Rheumatology, Hospital Universitario Japonés, Bolivia, Santa Cruz, Bolivia (Plurinational State of), ¹⁶Rheumatology Section, Cátedra de Reumatología de la Facultad de Medicina de la Universidad de la Republica, Uruguay, Montevideo, Uruguay, ¹⁷Biomab, Center for Arthritis, Bogota, Colombia, Bogota, Colombia, ¹⁸Rheumatology Section, Hospital Señor del Milagro de Salta, Argentina, Salta, Argentina, ¹⁹Rheumatology, University Hospital “Dr. José Eleuterio González”, UANL, Mexico, Monterrey, Mexico, ²⁰Rheumatology Section, Hospital Regional Universitario Presidente Estrella Ureña, República Dominicana, Santiago, Dominican Republic, ²¹Rheumatology, Centro Médico de Reumatología; Sucre, Bolivia, Sucre, Bolivia (Plurinational State of)
Background/Purpose: The SpENAT, a Spanish version of the Educational Needs Assessment Tool (ENAT), is a self-completed questionnaire that assesses educational needs (ENs) in ostheoathritis (OA)…
Abstract Number: 1420 • 2018 ACR/ARHP Annual Meeting
Prospective Validation of Cone Beam Computed Tomography for the Assessment of Disease Progression in Linear Scleroderma of the Face
Alessandra Meneghel¹, Stefano Puggina², Eleni Kamburi³, Giorgia Martini³, Fabio Vittadello³ and Francesco Zulian¹, ¹University of Padua, Department of Woman and Child Health, Padua, Italy, ²Unix Radiology Service, Affidea Group, Piove di Sacco, Italy, ³Department of Woman and Child Health, University of Padua, Padua, Italy
Background/Purpose: Currently, the techniques used for the monitoring of Localized Scleroderma of the face (LSF) have significant limitations. We prospectively evaluated the reliability of the…
Abstract Number: 2208 • 2018 ACR/ARHP Annual Meeting
Novel Fluorescence Optical Imaging Scoring System of Inflammation in the Hand and Wrist Is in Patients with Rheumatoid Arthritis – Agreement with Ultrasonography and Sensitivity to Change
Mads Ammitzbøll-Danielsen¹, Daniel Glinatsi¹, Lene Terslev² and Mikkel Østergaard^3,4, ¹Center for Rheumatology and Spine Diseases, Centre for Head and Orthopaedics, Rigshospitalet, Copenhagen Center for Arthritis Research, Copenhagen, Denmark, ²Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Rigshospitalet, Centre for Head and Orthopaedics, Rigshospitalet, Glostrup, Denmark, ³Center for Rheumatology and Spine Diseases, Rigshospitalet Glostrup Copenhagen Center for Arthritis Research, Copenhagen, Denmark, ⁴Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Background/Purpose: Fluorescence optical imaging (FOI) has been used for assessment of inflammation in the hands and has in several cross sectional studies been compared with…
Abstract Number: 2490 • 2018 ACR/ARHP Annual Meeting
Real World Evidence Describing Infliximab Utilization Patterns in Rheumatoid Arthritis Patients in Community Rheumatology Practices in the United States: Implications for Cost Efficiencies?
Sergio Schwartzman¹, Dennis Parenti², Shawn Black², Stephen Xu³, Wayne Langholff³ and Shelly Kafka², ¹Weill Cornell Medical College, New York, NY, ²Janssen Scientific Affairs, LLC, Horsham, PA, ³Janssen Research & Development, LLC, Spring House, PA
Background/Purpose: AWARE (Comparative and Pragmatic Study of Golimumab IV Versus Infliximab in Rheumatoid Arthritis) is an ongoing prospective Phase 4 comparator study designed to provide…
Abstract Number: 2598 • 2018 ACR/ARHP Annual Meeting
Efficacy of Anti-Tumor Necrosis Factor (TNF) Alpha Therapy, in Patients with Spondylarthritis in the University Center of Rouen in France, Divived to the Berlin Algorithm Modified By the Assessement Spondylarthritis Group: A Ten Years Retrospective Study
Christelle Princivil¹, thierry Lequerre², Didier Alcaix³ and Olivier Vittecoq⁴, ¹Jacques Monod hospital center, 76290 Montivilliers, France, montivilliers, France, ²Rheumatology Department, Rouen University Hospital, University of Rouen, 76031 Rouen, France., ROUEN, France, ³Rheumatology Department, Jacques Monod Hospital Center, 76290 Montivilliers, France, montivilliers, France, ⁴INSERM U905 & Normandy University, Institute for Research and Innovation in Biomedicine, Rouen, France
Background/Purpose: Treatments and diagnosis of SpA is a public health problem. The efficacy of anti-TNF alpha treatment is different from one patient to an other.…
Abstract Number: 2963 • 2018 ACR/ARHP Annual Meeting
Improving Clinically Inactive Disease in Patients with Juvenile Idiopathic Arthritis- a Quaternary Center Experience
Cagri Yildirim-Toruner¹, Ohoud AlAhmed², Fatima Barbar-Smiley³, Karla Jones³, Melanie Kohlheim⁴, Stephanie Lemle⁵, Darby MacDonald², Evan Mulvihill⁶, Edward Oberle², Aliese Sarkissian², Vidya Sivaraman⁷, Bethanne Thomas², Kelly Wise⁸ and Stacy P. Ardoin¹, ¹Division of Rheumatology, Nationwide Children’s Hospital, Columbus, OH, ²Pediatric Rheumatology, Nationwide Children's Hospital, Columbus, OH, ³Rheumatology, Nationwide Children's Hospital, Columbus, OH, ⁴Pediatric Rheumatology Care and Outcomes Improvement Network, Cincinnati, OH, ⁵Nationwide Children's Hospital, Columbus, OH, ⁶Pediatrics and Rheumatology, Nationwide Children's Hospital, Columbus, OH, ⁷Division of Rheumatology, Nationwide Children's Hospital, Columbus, OH, ⁸Specialty Pharmacy/Rheumatology, Nationwide Children's Hospital, Columbus, OH
Background/Purpose: Juvenile idiopathic arthritis (JIA), the most common pediatric rheumatologic diagnosis, influences many aspects of a child’s life. Although there is no known cure, disease…
Abstract Number: 1621 • 2017 ACR/ARHP Annual Meeting
Prevalence of Cognitive Impairment in Systemic Lupus Erythematosus Assessed By the Automated Neuropsychological Assessment Metrics
Zahi Touma¹, Robin Green², Lesley Ruttan³, Sabrina Lombardi³, Carmela Tartaglia⁴, Nicole Anderson⁵, Jiandong Su⁶, Kenneth Colosimo⁶, Michelle Vitti⁶, Dennisse Bonilla⁶, Joan E. Wither⁵, Marvin J. Fritzler⁷ and Dorcas Beaton⁸, ¹Rheumatology, University of Toronto, Division of Rheumatology, Institute of Health Policy, Management and Evaluation, Toronto, ON, Canada, ²Brain and Therapeutics, Toronto Rehabilitation Institute, Toronto, ON, Canada, ³Toronto Rehabilitation Institute, Toronto, ON, Canada, ⁴University of Toronto, Krembil Neurosciences Centre, Toronto, ON, Canada, ⁵Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ⁶University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ⁷Medicine, University of Calgary, Calgary, AB, Canada, ⁸Mobility Program Clinical Research Unit, St Michael's Hospital, Toronto, ON, Canada
Background/Purpose: The screening and diagnosis of Cognitive Impairment (CI) in Systemic Lupus Erythematosus (SLE) patients is often delayed. CI diagnosed according to the American College…
Abstract Number: 1870 • 2017 ACR/ARHP Annual Meeting
Validation of an Electronic Version of the Michigan Body Map
Chad M. Brummett¹, David Kohns², Rishi Bakshi³, Jenna Goesling⁴, Stephanie Moser¹, Jennifer Pierce⁴, David Williams⁵, Daniel J. Clauw⁵, Afton L. Hassett¹ and Erin Spencer², ¹Anesthesiology, University of Michigan, Ann Arbor, MI, ²University of Michigan, Ann Arbor, MI, ³Physical Medicine Rehabilitaion, Univeristy of Michigan, Ann Arbor, MI, ⁴Department of Anesthesiology, University of Michigan, Ann Arbor, MI, ⁵Chronic Pain & Fatigue Research Center, University of Michigan, Ann Arbor, MI
Background/Purpose: We previously validated the Michigan Body Map (MBM) to accurately assess widespread body pain and as a means of administering the Widespread Pain Index…
Abstract Number: 2010 • 2017 ACR/ARHP Annual Meeting
Does PET CT Matter in Assessing Extent of Disease in Relapsing Polychondritis – a Single Center Pilot Study
Aman Sharma¹, Adarsh MB², Shankar Naidu³, Varun Dhir⁴, Roshan Verma⁵, Rajender Basher⁵, Anish Bhattacharya⁶, Sanjay Jain⁷ and B R Mittal⁶, ¹Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India, ²Internal Medicine, PGIMER, Chandigarh, India, ³PGIMER, cHANDIGARH, India, ⁴Internal Medicine (Rheumatology Unit), Postgraduate Institute of Medical Education and Research, Chandigarh, India, ⁵PGIMER, Chandigarh, India, ⁶Nuclear Medicine, PGIMER, Chandigarh, India, ⁷PGIMER, CHANDIGARH, India
Background/Purpose: Relapsing polychondritis(RP) is a rare rheumatic disease involving cartilaginous and proteoglycan rich structures. Clinical examination and radiological investigations have limitations in assessing the extent…

1
2
3
…
6
Next Page »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].